Tissue Regenix Group plc (LON:TRX – Get Free Report) dropped 2.8% during mid-day trading on Wednesday . The stock traded as low as GBX 59.80 ($0.74) and last traded at GBX 59.80 ($0.74). Approximately 44,239 shares changed hands during trading, a decline of 33% from the average daily volume of 65,903 shares. The stock had previously closed at GBX 61.50 ($0.77).
Tissue Regenix Group Trading Down 0.8 %
The company has a current ratio of 4.03, a quick ratio of 2.36 and a debt-to-equity ratio of 32.01. The company’s fifty day moving average is GBX 64.51 and its 200-day moving average is GBX 58.28. The firm has a market capitalization of £43.05 million, a P/E ratio of -3,052.50 and a beta of 1.48.
About Tissue Regenix Group
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.
Featured Articles
- Five stocks we like better than Tissue Regenix Group
- What Does a Stock Split Mean?
- Comprehensive Analysis of PayPal Stock
- Airline Stocks – Top Airline Stocks to Buy Now
- Intuitive Surgical Stock Can Trend Much Higher This Year
- Earnings Per Share Calculator: How to Calculate EPS
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
